• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于头颈部鳞状细胞癌的新型分子分类系统:通过多组学分析预测治疗反应和转移潜能。

A novel molecular classification system for head and neck squamous cell carcinoma: predicting treatment response and metastatic potential through multi-omics analysis.

作者信息

Liu XinYu, Liu YuJun, Tian XuTengYue, Xi Yue, Lu MiaoMiao, Zou Xin, Chen WanTao

机构信息

College of Stomatology, Binzhou Medical University, Yantai, 264003, Shandong, China.

Department of Oral and Maxillofacial-Head and Neck Oncology, School of Medicine, Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, PR China.

出版信息

Discov Oncol. 2025 Apr 7;16(1):477. doi: 10.1007/s12672-025-02257-0.

DOI:10.1007/s12672-025-02257-0
PMID:40192963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11977092/
Abstract

BACKGROUND

Head and neck squamous cell carcinoma (HNSCC) demonstrates significant heterogeneity, necessitating improved molecular classification for precision treatment.

METHODS

We integrated single-cell and bulk RNA sequencing data from 59,376 cells across ten datasets using Scissor and scSTAR packages. Molecular subtyping was performed through ssGSEA and WGCNA analysis, with immune infiltration evaluated using CIBERSORT. We developed a machine learning-based risk prediction model using 54 algorithms.

RESULTS

We identified three molecular subtypes with distinct prognostic implications, showing significant survival differences across independent datasets (TCGA-HNSCC, P < 0.0001; GSE65858, P = 0.018). The C3 subtype showed enhanced immunotherapy response potential, while C2 exhibited the highest genomic alteration rate (97.06%) and TP53 mutations (80%). Macrophages emerged as key players in intercellular communication networks. Our risk prediction model demonstrated robust performance across four validation cohorts.

CONCLUSION

This molecular subtyping framework provides valuable insights for patient stratification and personalized therapeutic strategies in HNSCC, potentially improving clinical outcomes through precise treatment selection.

摘要

背景

头颈部鳞状细胞癌(HNSCC)表现出显著的异质性,需要改进分子分类以实现精准治疗。

方法

我们使用Scissor和scSTAR软件包整合了来自十个数据集的59376个细胞的单细胞和批量RNA测序数据。通过单样本基因集富集分析(ssGSEA)和加权基因共表达网络分析(WGCNA)进行分子亚型分类,使用CIBERSORT评估免疫浸润情况。我们使用54种算法开发了一种基于机器学习的风险预测模型。

结果

我们确定了三种具有不同预后意义的分子亚型,在独立数据集(TCGA-HNSCC,P < 0.0001;GSE65858,P = 0.018)中显示出显著的生存差异。C3亚型显示出增强的免疫治疗反应潜力,而C2亚型表现出最高的基因组改变率(97.06%)和TP53突变率(80%)。巨噬细胞成为细胞间通信网络中的关键参与者。我们的风险预测模型在四个验证队列中表现出强大的性能。

结论

这种分子亚型分类框架为HNSCC患者的分层和个性化治疗策略提供了有价值的见解,有可能通过精确的治疗选择改善临床结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/4e194bd93169/12672_2025_2257_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/84ab4b4b9d43/12672_2025_2257_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/1f6d7075566d/12672_2025_2257_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/6cacb51515de/12672_2025_2257_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/ca4d2d86ae53/12672_2025_2257_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/4e194bd93169/12672_2025_2257_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/84ab4b4b9d43/12672_2025_2257_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/1f6d7075566d/12672_2025_2257_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/6cacb51515de/12672_2025_2257_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/ca4d2d86ae53/12672_2025_2257_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904e/11977092/4e194bd93169/12672_2025_2257_Fig5_HTML.jpg

相似文献

1
A novel molecular classification system for head and neck squamous cell carcinoma: predicting treatment response and metastatic potential through multi-omics analysis.一种用于头颈部鳞状细胞癌的新型分子分类系统:通过多组学分析预测治疗反应和转移潜能。
Discov Oncol. 2025 Apr 7;16(1):477. doi: 10.1007/s12672-025-02257-0.
2
Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma.整合免疫多组学和机器学习以改善头颈部鳞状细胞癌的预后、免疫格局以及对一线和二线治疗的敏感性。
Sci Rep. 2024 Dec 28;14(1):31454. doi: 10.1038/s41598-024-83184-y.
3
Multiple machine learning-based integrations of multi-omics data to identify molecular subtypes and construct a prognostic model for HNSCC.基于机器学习的多组学数据多重整合,以识别头颈部鳞状细胞癌的分子亚型并构建预后模型。
Hereditas. 2025 Feb 6;162(1):17. doi: 10.1186/s41065-025-00380-0.
4
Multi omics analysis of mitophagy subtypes and integration of machine learning for predicting immunotherapy responses in head and neck squamous cell carcinoma.多组学分析自噬亚型和机器学习的整合,用于预测头颈部鳞状细胞癌的免疫治疗反应。
Aging (Albany NY). 2024 Jun 21;16(12):10579-10614. doi: 10.18632/aging.205964.
5
E2F expression profiling-based subtypes in head and neck squamous cell carcinoma: clinical relevance, prognostic implications, and personalized therapy.基于E2F表达谱的头颈部鳞状细胞癌亚型:临床相关性、预后意义及个性化治疗
World J Surg Oncol. 2025 Apr 24;23(1):157. doi: 10.1186/s12957-025-03808-z.
6
HISMD: A Novel Immune Subtyping System for HNSCC.HISMD:头颈癌新型免疫亚型系统。
J Dent Res. 2023 Mar;102(3):270-279. doi: 10.1177/00220345221134605. Epub 2022 Nov 4.
7
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of tumor-associated neutrophils of head and neck squamous cell carcinoma.单细胞RNA测序与批量RNA测序的综合分析揭示了头颈部鳞状细胞癌肿瘤相关中性粒细胞的分子特征。
BMC Cancer. 2025 May 1;25(1):821. doi: 10.1186/s12885-025-14179-9.
8
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction.多组学分析的整合揭示了基于表观遗传学的肺腺癌分子分类:对药物敏感性和免疫治疗反应预测的意义。
Front Pharmacol. 2025 Feb 19;16:1540477. doi: 10.3389/fphar.2025.1540477. eCollection 2025.
9
Dendritic cell-related hub genes in head-and-neck squamous cell carcinoma: implications for prognosis and immunotherapy.头颈部鳞状细胞癌中与树突状细胞相关的枢纽基因:对预后和免疫治疗的意义
Transl Cancer Res. 2024 Jul 31;13(7):3620-3636. doi: 10.21037/tcr-23-2360. Epub 2024 Jul 22.
10
Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.免疫炎症在头颈部鳞状细胞癌中的作用:肿瘤微环境、耐药性及临床结局
Front Genet. 2022 Dec 12;13:1085700. doi: 10.3389/fgene.2022.1085700. eCollection 2022.

本文引用的文献

1
CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics.CellChat用于从单细胞转录组学进行细胞间通讯的系统分析。
Nat Protoc. 2025 Jan;20(1):180-219. doi: 10.1038/s41596-024-01045-4. Epub 2024 Sep 16.
2
Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma.针对 MS4A4A:改善胶质母细胞瘤免疫治疗反应的新途径。
CNS Neurosci Ther. 2024 Jul;30(7):e14791. doi: 10.1111/cns.14791.
3
Themis: advancing precision oncology through comprehensive molecular subtyping and optimization.
泰米斯:通过全面的分子分型和优化,推进精准肿瘤学。
Brief Bioinform. 2024 May 23;25(4). doi: 10.1093/bib/bbae261.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
5
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.头颈部鳞状细胞癌细胞模型对泛 FGFR 抑制的耐药性取决于与临床结局相关的 EMT 表型。
Mol Cancer. 2024 Feb 21;23(1):39. doi: 10.1186/s12943-024-01954-8.
6
PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein.PDLIM7通过稳定粘着斑激酶蛋白促进甲状腺乳头状癌的肿瘤转移。
Thyroid. 2024 May;34(5):598-610. doi: 10.1089/thy.2023.0497. Epub 2024 Feb 20.
7
Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma.免疫细胞丰度和 T 细胞受体景观提示头颈部鳞状细胞癌的新患者分层策略。
Cancer Res Commun. 2023 Oct 20;3(10):2133-2145. doi: 10.1158/2767-9764.CRC-23-0155.
8
Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma.血管内皮生长因子家族与头颈部鳞状细胞癌
Anticancer Res. 2023 Oct;43(10):4315-4326. doi: 10.21873/anticanres.16626.
9
Real-world study of patients with locally advanced HNSCC in the community oncology setting.社区肿瘤环境中局部晚期头颈部鳞状细胞癌患者的真实世界研究。
Front Oncol. 2023 Aug 17;13:1155893. doi: 10.3389/fonc.2023.1155893. eCollection 2023.
10
5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.5'-核苷酸酶 CD73/NT5E 支持 HPV 阴性头颈部癌细胞中 EGFR 介导的侵袭。
J Biomed Sci. 2023 Aug 24;30(1):72. doi: 10.1186/s12929-023-00968-6.